Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Frontiers in Clinical Diabetes and Healthcare is Scopus-indexed (Q3, CiteScore 3.5), WoS ESCI, DOAJ. Published by Frontiers Media SA.
Checked against the index lists dated .
ISSN 2673-6616Verify ISSN ↗
Publisher: Frontiers Media SA
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 151 / 250 | 39th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–present, best quartile Q3, CiteScore 3.5.
Frontiers in Clinical Diabetes and Healthcare is Q3 in Endocrinology, Diabetes and Metabolism (rank 151 of 250), by CiteScore 2025.
Frontiers in Clinical Diabetes and Healthcare is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.5, which places it in quartile Q3 at the 39th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.837, quartile Q2, with an H-index of 15.
The publisher lists an article processing charge of about US$2,353 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Frontiers in Clinical Diabetes and Healthcare is published by Frontiers Media SA. Its ISSN is 2673-6616.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Frontiers in Clinical Diabetes and Healthcare has an h-index of 20 and a 2-year mean of 2.42 citations per paper (OpenAlex). Its Scopus CiteScore is 3.5, quartile Q3. On 2-year citations it ranks #115 of 246 Scopus journals in Endocrinology, Diabetes and Metabolism.
Frontiers in Clinical Diabetes and Healthcare published 91 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from China (18.9%), United States (10%) and India (5.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.